ALDX
Aldeyra Therapeutics·NASDAQ
--
--(--)
--
--(--)
6.77 / 10
Outperform
Sentiment 6.77/10 and fund‑flow score 7.99 indicate robust liquidity across all investor sizes. Analyst coverage is limited to one neutral rating, while the stock has fallen 65.6% recently, creating a mismatch with expectations.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-18
InstitutionHC Wainwright & Co.
Times predicted3
Historical Win Rate66.7%
What is the market sentiment for ALDX?
- ALDX holds a Bullish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 6.77/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
